Characterization of 24-h cortisol release in obese and non-obese hyperandrogenic women.
Excessive androgen output is a well-recognized feature of adrenocortical oversecretion in women with ovarian hyperandrogenism, or polycystic ovary disease (PCOD). However, evidence of a concomitant alteration of cortisol secretion is lacking even though obesity per se, a common clinical feature of PCOD, has been shown to be associated with cortisol oversecretion. To clarify whether a subtle alteration in cortisol secretion exists, a study of 24-h episodic cortisol release and post-prandial cortisol responses was undertaken in eight women with PCOD and eight normal women comprising equal numbers of obese and non-obese subjects. All four groups showed normal biphasic 24-h cortisol secretion profiles but cortisol pulse frequency was increased in the PCOD groups. Independently, both hyperandrogenism and obesity were associated with an accelerated cortisol clearance rate. These changes, together with normal or only slightly elevated 24-h cortisol integrated area under the curve, suggest an increased compensatory cortisol production in women with PCOD. Furthermore, subjects with PCOD and subjects with obesity showed different post-prandial cortisol responses to normal non-obese women. In conclusion, these subtle cortisol abnormalities may be a manifestation of altered central regulation of the hypothalamic-pituitary-adrenal axis and peripheral metabolic abnormalities, and may be linked to the pathophysiology of PCOD.
Miller
J E
JE
Division of Reproductive Endocrinology, State University of New York Health Sciences Center at Brooklyn.
Bray
M A
MA
Faiman
C
C
Reyes
F I
FI
D000328:Adult; D015992:Body Mass Index; D002940:Circadian Rhythm / Q000502:physiology*; D004435:Eating / Q000502:physiology; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism*; D017588:Hyperandrogenism / Q000097:blood* / Q000150:complications / Q000503:physiopathology; D007030:Hypothalamo-Hypophyseal System / Q000502:physiology; D009765:Obesity / Q000097:blood* / Q000150:complications / Q000503:physiopathology; D010913:Pituitary-Adrenal System / Q000502:physiology; D011085:Polycystic Ovary Syndrome / Q000097:blood* / Q000150:complications / Q000503:physiopathology
D006854:Hydrocortisone